New Release of Allegro CTMS@Site Takes Financial Management, Productivity, and Compliance to the Next Level
The Winter 2011 release of the clinical trial management system from Forte Research Systems includes enhancements to and new functionality in payments, patient stipend management, subject visit scheduling, and regulatory compliance.
MADISON, Wis., Jan. 5, 2012 /PRNewswire/ -- The recent quarterly release of the Allegro CTMS@Site system from Forte Research Systems includes a great deal of sought-after functionality. The clinical trial management system (CTMS) designed exclusively for investigator sites now includes investigator and vendor payments, patient stipend management, patient scheduling functionality, and re-consenting management among its many recent enhancements.
(Photo: http://photos.prnewswire.com/prnh/20101118/CG04162)
"With the addition of payments functionality and the other enhancements in this release, Allegro CTMS@Site is now the most comprehensive system available for investigator sites," said Srini Kalluri, CEO and Chief Customer Experience Officer at Forte Research Systems.
Enhancements in Allegro CTMS@Site Winter 2011 Version
Clinical trial financial management continues to be a top priority for investigator sites. With the new payments functionality in Allegro CTMS@Site, users can now quickly view payments that are ready to send or have been sent for all investigators and vendors. These lists are automatically generated and amounts are automatically calculated based on procedures or patient visits that have been completed. Additionally, sites can now budget for and track patient stipends on a per-protocol basis with the updated system. Enhancements to the revenue forecasting functionality in the system provide a month-by-month view of expected revenue based on the most current subject visit information.
The benefits of moving from spreadsheets or paper to a CTMS have never been more clearly demonstrated than with the new feature in Allegro CTMS@Site that allows scheduling of subject visits onto a staff member's calendar with two clicks. Staff are no longer required to copy their patients' planned visit dates from spreadsheets into their calendar. With Allegro CTMS@Site, scheduling is easily accomplished including the time of the visit and changes are automatically updated. Combined with the existing option to integrate the Allegro CTMS@Site event and task management functionality with Outlook, entire subject schedules can easily be generated and managed as an integral part of staff members' normal workflow.
Other productivity improvements include new functionality that allows staff to view all subject visits across all protocols in a month, week, or day. This helps with planning for patient visits as well as quickly catching any missed appointments that need to be rescheduled.
In addition to improving productivity, new functionality for re-consenting subjects also improves regulatory compliance. Allegro CTMS@Site now supports tracking of all of the subjects that require re-consenting, the expiration of old consent forms, and the handling of exceptions.
Further enhancing the system's features that support 21 CFR Part 11 compliance are new Audit and History sections added throughout the system.
"Compliance, control over clinical trial financials, and productivity are top concerns for our customers," Kalluri said. "With the benefit of their ongoing feedback and insights, we've once again delivered on each of these fronts."
About the Allegro Research on Demand Product Line
The Allegro® family of products are easy-to-use, intuitively designed, cloud-based systems that support clinical research operations excellence. Allegro CTMS@Site™ is designed exclusively for investigator sites engaged in industry-sponsored clinical trials.
To set up a demonstration of Allegro CTMS@Site, to attend an online webinar, or to learn more, please contact us.
SOURCE Forte Research Systems, Inc.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article